Tag Archive for: DMG

G2B at Pediatric Diffuse Midline Glioma International Meeting
EventsGate2Brain was honored to participate in the Pediatric Diffuse Midline Glioma (DMG) International Meeting,…
Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.
Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com